Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Hoyeraal-Hreidarsson syndrome in infants causes severe gastrointestinal issues.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

The skin of both rat strains showed similar lectin binding patterns.

The study found that a one-step antibody method is better than the LSAB method for accurately studying hair follicle structures without false positives.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Epigenetic changes in blood cells may contribute to alopecia areata.

The hr gene is linked to hair loss in Valle del Belice sheep.

The role of γδT-cells in causing alopecia areata remains unclear.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

BST2 is a key marker for hair loss disease alopecia areata.

The excimer laser may help hair regrow in alopecia areata patients.

The method effectively delivers vaccines through the skin without needles.

Adalimumab may cause severe hair loss in some patients.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

A young woman recovered well from rare simultaneous Hepatitis B and autoimmune hepatitis after treatment.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

HS needs personalized treatment plans and more research.

The study identified key immune cell differences between mild and severe alopecia areata.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.